Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas
Sponsor: Cxlusa
Terminated
Sufficient clinical results obtained to support study endpoints.
Other terminated trials from Cxlusa
- Degeneration · Apr 2017
- Degeneration · Feb 2017
- Degeneration · Feb 2017
- Keratoconus · Phase PHASE2 · Feb 2017
More terminations from Cxlusa
A PHASE2 clinical study on Corneal Diseases and Eye Diseases, this trial is terminated or withdrawn. The trial is conducted by Cxlusa and has accumulated 14 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Feb 2022 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Feb 2022 [monthly]
Terminated PHASE2
▶ Show 9 earlier versions
-
Jun 2020 — Jan 2021 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Feb 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE2
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Aug 2019 [monthly]
Recruiting PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Mar 2017 — Aug 2017 [monthly]
Recruiting PHASE2
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE2
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cxlusa
For direct contact, visit the study record on ClinicalTrials.gov .